InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-36.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by ZANTE GREG, Chief Financial Officer. Officer active across 1 company, notably Viking Therapeutics, Inc.. Cumulatively, 14 filings have been published. Activity tracked since 28 September 2021. The latest transaction was disclosed on 2 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
7,667 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093792:0
44,533 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002485:0
12,750 shares@ US$7.7718.4% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-117885:0
6,667 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088538:0
4,249 shares@ US$4.683.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-005522:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005116:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004231:0
28,334 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000929:0
7,500 shares@ US$13.0718.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024722:0
3,242 shares@ US$7.774.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024227:0
32,000 shares@ US$8.5250.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-022398:0
20,233 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001343:0
3,097 shares@ US$4.880.0004% mcap50.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-001988:0
6,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058246:0
14 of 14 declarations
About ZANTE GREG
Greg Zante is the Chief Financial Officer of Viking Therapeutics, Inc. In this role, he oversees the company's financial operations, including financial planning and reporting. With a strong background in finance, he plays a key role in managing financial resources and regulatory compliance. His expertise is essential in ensuring the financial health of Viking Therapeutics and supporting its mission of innovation.
